These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1208639)

  • 1. Increased disrupting effects of haloperidol on a conditioned avoidance response after 6-hydroxydopamine treatment.
    Monti JM; Ruiz M
    Pharmacol Biochem Behav; 1975; 3(5):943-5. PubMed ID: 1208639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Hydroxydopamine induced catecholamine depletion and passive avoidance learning in rats.
    Oei TP; Ng CP
    Pharmacol Biochem Behav; 1978 May; 8(5):553-6. PubMed ID: 674261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The actions of dopaminergic and noradrenergic antagonists on conditioned avoidance responses in intact and 6-hydroxydopamine-treated rats.
    Taboada ME; Souto M; Hawkins H; Monti JM
    Psychopharmacology (Berl); 1979 Mar; 62(1):83-8. PubMed ID: 108752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic administration of food colorings on activity levels and cognitive performance in developing rat pups treated with 6-hydroxydopamine.
    Shaywitz BA; Goldenring JR; Wool RS
    Neurobehav Toxicol; 1979; 1(1):41-7. PubMed ID: 551301
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of the haloperidol-induced blockade of a conditioned avoidance response by alpha-methyltyrosine.
    Monti JM; Ruiz M
    Eur J Pharmacol; 1973 Oct; 24(1):25-8. PubMed ID: 4756166
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploratory activity and conditioned avoidance acquistion after early postnatal 6-hydroxydopamine administration.
    Nyakas C; van Delft AM; Kaplanski J; Smelik PG
    J Neural Transm; 1973; 34(4):253-66. PubMed ID: 4775136
    [No Abstract]   [Full Text] [Related]  

  • 7. 6-Hydroxydopamine and avoidance: Possible role of response suppression.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):873-8. PubMed ID: 1208629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intra-amygdaloid injections of 6-hydroxy-dopamine on avoidance responding in rats.
    Ashford J; Jones BJ
    Br J Pharmacol; 1976 Mar; 56(3):255-61. PubMed ID: 1260169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of intraventricular administration of 6-hydroxydopamine on behavior of rats in approach and avoidance procedures: Reversal of avoidance decrements by diazepam.
    Beer B; Lenard LG
    Pharmacol Biochem Behav; 1975; 3(5):879-86. PubMed ID: 1208630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of avoidance performance by intrastriatal administration of 6-hydroxydopamine.
    Neill DB; Boggan WO; Grossman SP
    Pharmacol Biochem Behav; 1974; 2(1):97-103. PubMed ID: 4597522
    [No Abstract]   [Full Text] [Related]  

  • 11. The impairment of learning of conditioned avoidance response in rats after 6-hydroxydopamine.
    Plech A; Herman ZS; Brus R; Drybanski A
    Act Nerv Super (Praha); 1975 Sep; 17(3):176-8. PubMed ID: 1199684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 15. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
    Feng M; Sparkman NL; Sui N; Li M
    J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of local injection of 6-hydroxydopamine in the medial ventral tegmentum in the rat. Possible role of the mesolimbic dopamingergic system.
    Le Moal M; Galey D; Cardo B
    Brain Res; 1975 Apr; 88(1):190-4. PubMed ID: 1122401
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of raclopride and haloperidol on spontaneous motor activity and on conditioned avoidance behavior in rats. A comparison of potency, efficacy and time-course of action.
    Wadenberg ML; Ahlenius S
    Arzneimittelforschung; 1991 Jul; 41(7):692-5. PubMed ID: 1772455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specificity of the effect on the avoidance conditionning of microinjections of 6-hydroxydopamine in rat nigro-striatal system].
    Echavarria-Mage MT; Senault B; Delacour J
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):905-7. PubMed ID: 820478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity.
    Kovács GL; de Wied D
    Eur J Pharmacol; 1978 Dec; 53(1):103-7. PubMed ID: 738353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pretreatment with 6-hydroxydopamine or noradrenergic receptor blockers on the clonidine-induced distruption of conditioned avoidance responding.
    Hawkins M; Monti JM
    Eur J Pharmacol; 1979 Sep; 58(1):53-8. PubMed ID: 499336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.